Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4IG gene therapies

Transplantation

Volumn 76, Issue 7, 2003, Pages 1089-1096

  Yamashita, Kenichiro ^a   Masunaga, Taro ^b   Yanagida, Naoyuki ^a   Takehara, Megumi ^a   Hashimoto, Taku ^a   Kobayashi, Tokushi ^a   Echizenya, Hayato ^a   Hua, Nan ^a   Fujita, Miri ^c   Murakami, Masaaki ^b   Furukawa, Hiroyuki ^a   Uede, Toshimistu ^b   Todo, Satoru ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c Muroran City General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; B7 ANTIGEN; BETA GALACTOSIDASE; CD28 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; GENE THERAPY; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART GRAFT; HETEROTOPIC TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN GRAFT; T LYMPHOCYTE ACTIVATION; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; CELL DIVISION; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOCONJUGATES; LYMPH NODES; LYMPHOCYTES; MALE; MYOCARDIUM; POSTOPERATIVE PERIOD; RATS; RATS, INBRED ACI; RATS, INBRED BN; RATS, INBRED LEW; SKIN TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC; TRANSGENES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 17144472042     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000085651.20586.30     Document Type: Article

References (32)

1. Clark LB, Foy TM, Noelle RJ. CD40 and its ligand. Adv Immunol 1996; 63: 43.
2. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233.
3. Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002; 20: 29.
4. Frauwirth KA, Thompson CB. Activation and inhibition of lymphocytes by costimulation. J Clin Invest 2002; 109(3): 295.
5. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338(25): 1813.
6. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248(4961): 1349.
7. Lin H, Bolling SF, Linsley PS, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993; 178(5): 1801.
8. Pearson TC, Alexander DZ, Winn KJ, et al. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57(12): 1701.
9. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381(6581): 434.
10. Kirk AD, Tadaki DK, Celniker A, et al. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. Transplantation 2001; 72(3): 377.
11. Parker DC, Greiner DL, Phillips NE, et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci U S A 1995; 92(21): 9560.
12. Kenyon NS, Chatzipetrou M, Masetti M, et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A 1999; 96(14): 8132.
13. Kirk AD, Burkly LC, Batty DS, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999; 5(6): 686.
14. Li Y, Li XC, Zheng XX, et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999; 5(11): 1298.
15. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 1997; 94(16): 8789.
16. Yanagida N, Nomura M, Yamashita K, et al. Tolerance induction by a single donor pretreatment with the adenovirus vector encoding CTLA4Ig gene in rat orthotopic liver transplantation. Transplant Proc 2001; 33(1-2): 573.
17. Nomura M, Yamashita K, Murakami M, et al. Induction of donor-specific tolerance by adenovirus-mediated CD40Ig gene therapy in rat liver transplantation. Transplantation 2002; 73: 1403.
18. Takehara M, Murakami M, Inobe M, et al. Long-term acceptance of allografts by in vivo gene transfer of regulatable adenovirus vector containing CTLA4IgG and loxP. Hum Gene Ther 2001; 12(4): 415.
19. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
20. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990; 9(6): 587.
21. Kay MA, Meuse L, Gown AM, et al. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. Proc Natl Acad Sci U S A 1997; 94(9): 4686.
22. Silvers WK, Wachtel SS, Poole TW. The behavior of skin grafts incompatible with respect to skin alloantigens on mice rendered tolerant at birth with lymphoid cells. J Exp Med 1976; 143(6): 1317.
23. Motoyama K, Arima T, Yu S, et al. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration. Transplantation 2000; 69(2): 285.
24. Lakkis FG, Arakelov A, Konieczny BT, et al. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000; 6(6): 686.
25. West LJ, Tao K. Acceptance of third-party cardiac but not skin allografts induced by neonatal exposure to semi-allogeneic lymphohematopoietic cells. Am J Transplant 2002; 2(8): 733.
26. Sun H, Subbotin V, Chen C, et al. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation 1997; 64(12): 1838.
27. Shimizu K, Schonbeck U, Mach F, et al. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol 2000; 165(6): 3506.
28. Guillot C, Mathieu P, Coathalem H, et al. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. J Immunol 2000; 164: 5258.
29. Ensminger SM, Witzke O, Spriewald BM, et al. CD8+ T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade. Transplantation 2000; 69(12): 2609.
30. Tullius SG, Nieminen-Kelha M, Buelow R, et al. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 2002; 74(5): 591.
31. Soares MP, Lin Y, Anrather J, et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998; 4(9): 1073.
32. Bach FH, Ferran C, Hechenleitner P, et al. Accommodation of vascularized xenografts; expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nature Medicine 1997; 3(2): 196.